Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec

Jonathan T Blackmon; Michael S Stratton; Young Kwak; Peter G Pavlidakey; Andrzej T Slominski; Svetlana B McKee; Toni M Viator; Ju Young Kim; Conway C Huang; Robert M Conry

doi:10.1016/j.jdcr.2017.02.011

Inflammatory melanoma in transit metastases with complete response to talimogene laherparepvec

JAAD Case Rep. 2017 Jun 16;3(4):280-283. doi: 10.1016/j.jdcr.2017.02.011. eCollection 2017 Jul.

Authors

Affiliations

¹ Covenant College, Lookout Mountain, Georgia.
² Deparment of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
³ Division of Dermatology and Pathology, University of Alabama at Birmingham, Birmingham, Alabama.
⁴ Division of Dermatopathology, University of Alabama at Birmingham, Birmingham, Alabama.
⁵ Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
⁶ Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama.
⁷ Navigate BioPharm Services, Inc, a Novartis company, Carlsbad, California.
⁸ Division of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.

No abstract available

Keywords: TVEC, Talimogene laherparepvec; dermal intercalation; dermal lymphatics; erythematous plaque; immune phenotype; inflammatory melanoma; talimogene laherparepvec.

Publication types

Case Reports